Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00663936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Multi-center, Randomized, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of T-817MAa in Patients With Mild to Moderate Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to evaluate the efficacy of T-817MA in AD patients to treat dementia. Efficacy will be cognitive function, as measured by the ADAS-cog cognitive assessment. The secondary objectives of the study are to evaluate the safety of T-817MA and the activities of daily living (assessed with the ADCS-ADL) of AD patients taking T-817MA, and to evaluate the efficacy of T-817MA in AD patients with an overall global assessment using the ADCS-CGIC.
Study identification
- NCT ID
- NCT00663936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 373 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- Jun 2011 (Actual)
- Last update posted
- Nov 5, 2013
2008 – 2011
United States locations
- U.S. sites
- 33
- U.S. states
- 14
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | — |
| Northwest NeuroSpecialists | Tucson | Arizona | 85741 | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove | California | 92845 | — |
| Southwest Institute for Clinical Research, Inc. | Rancho Mirage | California | 92270 | — |
| Pacific Research Network, Inc. | San Diego | California | 92103 | — |
| San Francisco Clinical Research Center | San Francisco | California | 94109 | — |
| Radiant Research | Denver | Colorado | 80239 | — |
| Geriatric and Adult Psychiatry, LCC | Hamden | Connecticut | 06518 | — |
| Research Center for Clinical Studies, Inc. | Norwalk | Connecticut | 06851 | — |
| NeuroPsychiatric Center of the Palm Beaches | Boynton Beach | Florida | 33426 | — |
| Galiz Research | Miami Springs | Florida | 33166 | — |
| Anchor Research Center | Naples | Florida | 34102 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Axiom Clinical Research of Florida | Tampa | Florida | 33609 | — |
| Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute | Tampa | Florida | 33613 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Columbus Research & Wellness Institute | Columbus | Georgia | 31907 | — |
| Agewell | Indianapolis | Indiana | 46260 | — |
| Cleveland Clinic - Lou Ruvo Center for Brain Health | Las Vegas | Nevada | 89106 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Memory Enhancement Center of America | Toms River | New Jersey | 08755 | — |
| Brooklyn Medical Institute | Brooklyn | New York | 11214 | — |
| SPRI Clinical Trials | Brooklyn | New York | 11235 | — |
| Alzheimer's Disease Center, U. of Rochester Medical Center | Rochester | New York | 14620 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10312 | — |
| The Alzheimer's Memory Center | Charlotte | North Carolina | 28211 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Raleigh Neurology Associates | Raleigh | North Carolina | 27607 | — |
| Clinical Trials of America, Inc. | Winston-Salem | North Carolina | 27103 | — |
| The Clinical Trials Center | Jenkintown | Pennsylvania | 19046 | — |
| CRI Worldwide, LLC | Philadelphia | Pennsylvania | 19139 | — |
| Innovative Clinical Trials | San Antonio | Texas | 78229 | — |
| IPC Research | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00663936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2013 · Synced Oct 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00663936 live on ClinicalTrials.gov.